Related Experiment Video

Updated: Aug 14, 2026

Investigating Angiogenesis on a Functional and Molecular Level by Leveraging the Scratch Wound Migration Assay and the Spheroid Sprouting Assay
09:16

Investigating Angiogenesis on a Functional and Molecular Level by Leveraging the Scratch Wound Migration Assay and the Spheroid Sprouting Assay

Published on: May 31, 2024

Advances in understanding angiogenesis through molecular studies

Mijung Kwon1, Steven K Libutti

  • 1Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-1201, USA.

International Journal of Radiation Oncology, Biology, Physics
|December 27, 2005
PubMed

Insights

Tumor growth relies on angiogenesis, the formation of new blood vessels. Understanding the molecular mechanisms of antiangiogenic therapies, aided by microarray technology, is crucial for developing effective anticancer treatments.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Tumor growth necessitates angiogenesis, regulated by proangiogenic and antiangiogenic factors.
  • Inhibiting tumor angiogenesis is a key anticancer therapeutic strategy, with numerous compounds in clinical trials.
  • The precise molecular mechanisms of many antiangiogenic compounds remain poorly understood.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying the action of antiangiogenic compounds.
  • To identify novel molecules and pathways involved in tumor angiogenesis using advanced technologies.
  • To review experimental approaches for elucidating tumor-host interactions in angiogenesis.

Main Methods:

  • Utilizing microarray technology to rapidly and extensively analyze gene expression.
  • Combining microarray analysis with novel experimental approaches.
  • Investigating molecular pathways involved in tumor-host interactions.

Main Results:

  • Microarray technology has revealed novel molecules and pathways critical to angiogenesis.
  • New experimental strategies combined with microarray analysis aid in identifying molecular pathways.
  • Elucidation of angiogenic and antiangiogenic pathways is progressing.

Conclusions:

  • Understanding the molecular basis of angiogenesis is essential for advancing cancer therapy.
  • Microarray technology offers a powerful tool for dissecting complex biological processes like angiogenesis.
  • Further research into angiogenic and antiangiogenic pathways will lead to improved anticancer treatments.

More Related Videos

Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies09:03

Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies

Published on: June 30, 2023

The Arteriovenous (AV) Loop in a Small Animal Model to Study Angiogenesis and Vascularized Tissue Engineering08:53

The Arteriovenous (AV) Loop in a Small Animal Model to Study Angiogenesis and Vascularized Tissue Engineering

Published on: November 2, 2016

Related Concept Videos

Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Overview of Cell-Matrix Interactions01:24

Overview of Cell-Matrix Interactions

The extracellular matrix or ECM holds cells together to form a tissue and allows the cells within the tissue to communicate. ECM comprises proteins such as fibronectin, collagen, laminin, etc. The most abundant protein in this space is collagen. Collagen fibers are interwoven with carbohydrate-containing protein molecules called proteoglycans. ECM allows cell migration and provides a structural scaffold at cell adhesion that anchors the cell when the extracellular matrix proteins interact with...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...